TY - JOUR
T1 - Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer
AU - the Urologic Oncology Study Group of the Japan Clinical Oncology Group (JCOG)
AU - Inokuchi, Junichi
AU - Kuroiwa, Kentaro
AU - Nishiyama, Hiroyuki
AU - Kojima, Takahiro
AU - Kakehi, Yoshiyuki
AU - Sugimoto, Mikio
AU - Takenaka, Atsushi
AU - Fujimoto, Kiyohide
AU - Yamaguchi, Raizo
AU - Habuchi, Tomonori
AU - Hashine, Katsuyoshi
AU - Mizusawa, Junki
AU - Eba, Junko
AU - Naito, Seiji
AU - Shinohara, N.
AU - Masumori, N.
AU - Ohyama, C.
AU - Ito, A.
AU - Kawamura, S.
AU - Tsuchiya, N.
AU - Ito, K.
AU - Ichikawa, T.
AU - Fujimoto, H.
AU - Egawa, S.
AU - Iwamura, M.
AU - Tanigawa, T.
AU - Ishizuka, O.
AU - Miyake, H.
AU - Niwakawa, M.
AU - Gotoh, M.
AU - Inoue, T.
AU - Ogawa, O.
AU - Nishumura, K.
AU - Matsuyama, H.
AU - Eto, M.
AU - Yokomizo, A.
AU - Kamba, T.
N1 - Funding Information:
This study was supported in part by the National Cancer Center Research and Development Fund (23‐A‐20, 26‐A‐4, 29‐A‐3, 2020‐J‐3). We are grateful to the members of the JCOG Data Center and JCOG Operations Office for their support in preparing the manuscript (Keita Sasaki), data management (Kazumi Kubota, Shoko Todo) and oversight of the study management (Haruhiko Fukuda). We thank Jane Charbonneau, DVM, from Edanz Group ( www.edanzediting.com/ac ) for editing a draft of this manuscript.
Funding Information:
This study was supported in part by the National Cancer Center Research and Development Fund (23-A-20, 26-A-4, 29-A-3, 2020-J-3). We are grateful to the members of the JCOG Data Center and JCOG Operations Office for their support in preparing the manuscript (Keita Sasaki), data management (Kazumi Kubota, Shoko Todo) and oversight of the study management (Haruhiko Fukuda). We thank Jane Charbonneau, DVM, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript. The institutions and investigators that participated to this study besides those listed as co-authors are: N Shinohara, Department of Urology, Hokkaido University Graduate School of Medicine, Sapporo; N Masumori, Department of Urology, Sapporo Medical University School of Medicine, Sapporo; C Ohyama, Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki; A Ito, Department of Urology, Tohoku University Graduate School of Medicine, Sendai; S Kawamura, Department of Urology, Miyagi Cancer Center, Natori; N Tsuchiya, Department of Urology, Yamagata University Hospital, Yamagata; K Ito, Department of Urology, National Defense Medical College, Tokorozawa; T Ichikawa, Department of Urology, Graduate School of Medicine, Chiba University, Chiba; H Fujimoto, Urology Division, National Cancer Center Hospital, Tokyo; S Egawa, Department of Urology, Jikei University School of Medicine, Tokyo; M. Iwamura, Department of Urology, Kitasato University School of Medicine, Sagamihara; T Tanigawa, Department of Urology, Niigata Cancer Center Hospital, Niigata; O Ishizuka, Department of Urology, Shinshu University School of Medicine, Matsumoto; H Miyake, Department of Urology, Hamamatsu University School of Medicine, Hamamatsu; M Niwakawa, Division of Urology, Shizuoka Cancer Center, Shizuoka; M Gotoh, Department of Urology, Nagoya University Graduate School of Medicine, Nagoya; T Inoue, Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu; O Ogawa, Department of Urology, Kyoto University, Kyoto; K Nishumura, Department of Urology, Osaka International Cancer Institute, Osaka; H Matsuyama, Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube; M Eto, Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka; A Yokomizo, Department of Urology, Harasanshin Hospital, Fukuoka; and T Kamba, Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto.
Publisher Copyright:
© 2020 The Japanese Urological Association
PY - 2021/2
Y1 - 2021/2
N2 - Objectives: To investigate the impact on intravesical recurrence and prognosis according to the ureteral ligation timing during radical nephroureterectomy for upper urinary tract urothelial carcinoma. Methods: We carried out a retrospective chart review of 664 patients with non-metastatic upper urinary tract urothelial carcinoma who underwent radical nephroureterectomy with ureteral ligation (supplementary analysis of JCOG1110A). We excluded patients with previous and/or synchronous bladder cancer, clinically node-positive disease, no ureteral ligation data, those without ureteral ligation and those with any missing data. We investigated the cumulative incidence of intravesical recurrence and cancer-specific mortality, and overall survival between patients with ureteral ligation before renovascular ligation (early ureteral ligation), or ureteral ligation after renovascular ligation (late ureteral ligation). Results: Early and late ureteral ligation was carried out in 243 patients (36.6%) and 421 patients (63.4%), respectively. Intravesical recurrence occurred in 218 patients (32.8%) during follow up (median 3.9 years). No significant difference in the intravesical recurrence was found between early and late ureteral ligation groups. Meanwhile, survival in the early ureteral ligation group was significantly worse compared with the late ureteral ligation group. Multivariable analysis showed that early ureteral ligation was an independent prognostic factor for overall survival (hazard ratio 1.88, 95% confidence interval 1.24–2.85, P = 0.003) and cancer-specific mortality (hazard ratio 1.93, 95% confidence interval 1.14–3.25, P = 0.014). Conclusions: Our findings suggest that the incidence of intravesical recurrence is not affected by the timing of ureteral ligation during radical nephroureterectomy. However, early ureteral ligation might have a negative impact on survival outcomes.
AB - Objectives: To investigate the impact on intravesical recurrence and prognosis according to the ureteral ligation timing during radical nephroureterectomy for upper urinary tract urothelial carcinoma. Methods: We carried out a retrospective chart review of 664 patients with non-metastatic upper urinary tract urothelial carcinoma who underwent radical nephroureterectomy with ureteral ligation (supplementary analysis of JCOG1110A). We excluded patients with previous and/or synchronous bladder cancer, clinically node-positive disease, no ureteral ligation data, those without ureteral ligation and those with any missing data. We investigated the cumulative incidence of intravesical recurrence and cancer-specific mortality, and overall survival between patients with ureteral ligation before renovascular ligation (early ureteral ligation), or ureteral ligation after renovascular ligation (late ureteral ligation). Results: Early and late ureteral ligation was carried out in 243 patients (36.6%) and 421 patients (63.4%), respectively. Intravesical recurrence occurred in 218 patients (32.8%) during follow up (median 3.9 years). No significant difference in the intravesical recurrence was found between early and late ureteral ligation groups. Meanwhile, survival in the early ureteral ligation group was significantly worse compared with the late ureteral ligation group. Multivariable analysis showed that early ureteral ligation was an independent prognostic factor for overall survival (hazard ratio 1.88, 95% confidence interval 1.24–2.85, P = 0.003) and cancer-specific mortality (hazard ratio 1.93, 95% confidence interval 1.14–3.25, P = 0.014). Conclusions: Our findings suggest that the incidence of intravesical recurrence is not affected by the timing of ureteral ligation during radical nephroureterectomy. However, early ureteral ligation might have a negative impact on survival outcomes.
KW - intravesical recurrence
KW - prognosis
KW - radical nephroureterectomy
KW - upper urinary tract urothelial cancer
KW - ureteral ligation
UR - http://www.scopus.com/inward/record.url?scp=85096866679&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096866679&partnerID=8YFLogxK
U2 - 10.1111/iju.14435
DO - 10.1111/iju.14435
M3 - Article
C2 - 33283389
AN - SCOPUS:85096866679
SN - 0919-8172
VL - 28
SP - 208
EP - 214
JO - International Journal of Urology
JF - International Journal of Urology
IS - 2
ER -